Atrás
Rango del Día
$6.99
$7.39
Rango de 52 Semanas
$2.41
$8.72
Volumen
941,058
Promedio 50D / 200D
$6.41
/
$5.73
Cierre Anterior
$7.03
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -3.2 | 0.4 |
| P/B | 3.1 | 2.9 |
| ROE % | -109.9 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Puntos Clave
Debt/Equity of 0.12 — conservative balance sheet
Negative free cash flow of -157.44M
PEG of 0.08 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-109.90%
ROIC-66.81%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.12
Current Ratio6.14
Interest Coverage0.00
Valoración
P/E Ratio
-3.19
P/B Ratio3.09
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -174.33M |
| ROE | -109.90% | ROA | -74.97% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -157.44M |
| ROIC | -66.81% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.12 | Current Ratio | 6.14 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.19 | P/B Ratio | 3.09 |
| P/S Ratio | N/A | PEG Ratio | 0.08 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 556.28M | Enterprise Value | 517.54M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 8.09M | 13.62M |
| Net Income | -174.33M | -124.70M | -96.02M | -85.98M | -72.19M |
| EPS (Diluted) | -1.99 | -3.06 | -4.83 | -10.10 | -10.14 |
| Gross Profit | -1.64M | -2.46M | -2.58M | 8.09M | 13.62M |
| Operating Income | -179.21M | -129.73M | -104.32M | -106.45M | -72.25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 232.54M | 188.66M | 164.94M | 260.25M | 232.38M |
| Total Liabilities | 52.53M | 51.42M | 38.46M | 48.59M | 24.17M |
| Shareholders' Equity | 180.01M | 137.25M | 126.48M | 211.67M | 208.21M |
| Total Debt | 21.16M | 24.18M | 26.27M | 28.55M | 2.06M |
| Cash & Equivalents | 59.90M | 80.24M | 74.02M | 155.38M | 119.14M |
| Current Assets | 205.46M | 157.30M | 129.73M | 219.64M | 222.61M |
| Current Liabilities | 33.47M | 30.26M | 14.52M | 22.51M | 23.60M |